Structure-function analysis of vitamin D2 analogs as potential inducers of leukemia differentiation and inhibitors of prostate cancer proliferation

Journal of Steroid Biochemistry and Molecular Biology

Volumn 126, Issue 1-2, 2011, Pages 46-54

  Baurska, H ^a   Klopot, A ^a   Kielbinski, M ^b   Chrobak, A ^a,d   Wijas, E ^a   Kutner, A ^c   Marcinkowska, E ^a  

^a UNIVERSITY OF WROC AW   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

^d INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

1,25 Dihydroxyvitamin D3; Acute myeloid leukemia; CYP24A1; Differentiation; Proliferation; Prostate cancer; Vitamin D2 analogs

Indexed keywords

ANTINEOPLASTIC AGENT; CALCITRIOL; CCAAT ENHANCER BINDING PROTEIN BETA; CYTOCHROME P450 24A1; CYTOCHROME P450 ISOENZYME; ERGOCALCIFEROL DERIVATIVE; MESSENGER RNA; PRI 1906; PRI 1907; PRI 1908; PRI 1909; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HL 60; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; PROSTATE CANCER; STRUCTURE ACTIVITY RELATION;

ACTIVE TRANSPORT, CELL NUCLEUS; AGED; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL DIFFERENTIATION; CELL PROLIFERATION; ERGOCALCIFEROLS; FEMALE; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RECEPTORS, CALCITRIOL; RNA, MESSENGER; STEROID HYDROXYLASES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79958787552     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2011.04.006     Document Type: Article

References (44)

1. E. Mellanby, Experimental rickets. Medical Research (G.B.), Special Report Series SRS61 (4), 1921, pp. 1-78.
2. 3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells Leuk. Res. 7 1 1983 51 55 (Pubitemid 13113773)
3. 3 Proc. Natl. Acad. Sci. U. S. A. 78 8 1981 4990 4994 (Pubitemid 12225607)
4. 3: basic concepts J. Steroid Biochem. Mol. Biol. 97 1-2 2005 93 101 (Pubitemid 41546218)
5. K.K. Deeb, D.L. Trump, and C.S. Johnson Vitamin D signalling pathways in cancer: potential for anticancer therapeutics Nat. Rev. Cancer 7 9 2007 684 700 (Pubitemid 47327412)
6. 3 and skin diseases Arch. Dermatol. Res. 284 1 1992 S30 S36
7. A.S. Dusso, A.J. Brown, and E. Slatopolsky Vitamin D Am. J. Physiol. Renal Physiol. 289 1 2005 F8 F28
8. M.T. Mizwicki, D. Menegaz, S. Yaghmaei, H.L. Henry, and A.W. Norman A molecular description of ligand binding to the two overlapping binding pockets of the nuclear vitamin D receptor (VDR): structure-function implications J. Steroid Biochem. Mol. Biol. 121 1-2 2010 98 105
9. 3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells Biochem. Biophys. Res. Commun. 241 2 1997 419 426 (Pubitemid 28020116)
10. 3-induced differentiation of human leukemia HL60 cells Exp. Cell Res. 258 2 2000 425 437 (Pubitemid 30483521)
11. 3 Cell Cycle 8 5 2009 736 741
12. E. Marcinkowska, A. Wiedlocha, and C. Radzikowski Evidence that phosphatidylinositol 3-kinase and p70S6K protein are involved in differentiation of HL-60 cells induced by calcitriol Anticancer Res. 18 5 A 1998 3507 3514 (Pubitemid 28546483)
13. 3 and participates in its anti-apoptotic effect and cell cycle control in differentiating HL60 cells Cell Cycle 5 4 2006 447 451
14. C. Carlberg, and F. Molnar Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands Curr. Top. Med. Chem. 6 12 2006 1243 1253 (Pubitemid 44110913)
15. A. Opolski, J. Wietrzyk, A. Chrobak, E. Marcinkowska, E. Wojdat, A. Kutner, and C. Radzikowski Antiproliferative activity in vitro of side-chain analogues of calcitriol against various human normal and cancer cell lines Anticancer Res. 19 6b 1999 5217 5222 (Pubitemid 30103351)
16. 2 (24E)-(1S)-24-Dehydro-24a-homo-1,25-dihydroxyergocalciferol and congeners Steroids 67 9 2002 789 798 (Pubitemid 34765668)
17. E. Marcinkowska, and A. Kutner Side-chain modified vitamin D analogs require activation of both PI3-K and erk1,2 signal transduction pathways to induce differentiation of human promyelocytic leukemia cells Acta Biochim. Pol. 49 2 2002 393 406 (Pubitemid 135686786)
18. J. Wietrzyk, D. Nevozhay, M. Milczarek, B. Filip, and A. Kutner Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model Cancer Chemother. Pharmacol. 62 5 2008 787 797
19. M. Cui, A. Klopot, Y. Jiang, and J.C. Fleet The effect of differentiation on 1 25 dihydroxyvitamin D-mediated gene expression in the enterocyte-like cell line, Caco-2 J. Cell. Physiol. 218 1 2009 113 121
20. A. Kutner, M. Odrzywolska, M. Chodynski, J. Zorgdrager, J.P. van de Velde, Nowe analogi 1,25-dihydroksycholekalcyferolu i sposób ich otrzymywania. PL 190579 B1, 2005.
21. 3 compounds: separation of calcium and cell differentiation activities Biochemistry 29 1990 190 196 (Pubitemid 20033724)
22. R. Gallagher, S. Collins, J. Trujillo, K. McCredie, M. Ahearn, S. Tsai, R. Metzgar, G. Aulakh, R. Ting, F. Ruscetti, and R. Gallo Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia Blood 54 1979 713 733 (Pubitemid 10227870)
23. R. Morosetti, D.J. Park, A.M. Chumakov, I. Grillier, M. Shiohara, A.F. Gombart, T. Nakamaki, K. Weinberg, and H.P. Koeffler A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation Blood 90 7 1997 2591 2600 (Pubitemid 27413468)
24. 3-induced differentiation of AML cells carrying various mutations Leuk. Res. 34 5 2010 649 657
25. A. Racz, and J. Barsony Hormone-dependent translocation of vitamin D receptors is linked to transactivation J. Biol. Chem. 274 27 1999 19352 19360
26. E. Gocek, M. Kielbinski, and E. Marcinkowska Activation of intracellular signaling pathways is necessary for an increase in VDR expression and its nuclear translocation FEBS Lett. 581 9 2007 1751 1757 (Pubitemid 46602265)
27. E. Gocek, M. Kielbinski, P. Wyłob, A. Kutner, and E. Marcinkowska Side-chain modified vitamin D analogs induce rapid accumulation of VDR in the cell nuclei proportionately to their differentiation-inducing potential Steroids 73 14 2008 1359 1366
28. A. Klopot, K.W. Hance, S. Peleg, J. Barsony, and J.C. Fleet Nucleo-cytoplasmic cycling of the vitamin D receptor in the enterocyte-like cell line, Caco-2 J. Cell. Biochem. 100 3 2007 617 628 (Pubitemid 46180526)
29. 3 (Ro-26-9228) Mol. Endocrinol. 18 4 2004 874 887 (Pubitemid 38429479)
30. T. Graf Differentiation plasticity of hematopoietic cells Blood 99 9 2002 3089 3101 (Pubitemid 34525285)
31. V. Poli The role of C/EBP isoforms in the control of inflammatory and native immunity functions J. Biol. Chem. 273 45 1998 29279 29282 (Pubitemid 28509923)
32. N.A. Timchenko, A.L. Welm, X. Lu, and L.T. Timchenko CUG repeat binding protein (CUGBP1) interacts with the 5′ region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms Nucleic Acids Res. 27 22 1999 4517 4525 (Pubitemid 29533195)
33. E. Marcinkowska, E. Garay, E. Gocek, A. Chrobak, X. Wang, and G.P. Studzinski Regulation of C/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3 Exp. Cell Res. 312 11 2006 2054 2065 (Pubitemid 43850930)
34. 3-induced monocytic differentiation of HL60 cells Cancer Res. 64 1 2004 370 377 (Pubitemid 38114120)
35. H. Quentmeier, J. Reinhardt, M. Zaborski, and H.G. Drexler FLT3 mutations in acute myeloid leukemia cell lines Leukemia 17 1 2003 120 124 (Pubitemid 36175896)
36. http://www.dsmz.de/human-and-animal-cell-lines
37. E. Gocek, and G.P. Studzinski Vitamin D and differentiation in cancer Crit. Rev. Clin. Lab. Sci. 46 4 2009 190 209
38. M.C. McElwain, R.A. Modzelewski, W.D. Yu, D.M. Russell, and C.S. Johnson Vitamin D: an antiproliferative agent with potential for therapy of squamous cell carcinoma Am. J. Otolaryngol. 18 5 1997 293 298 (Pubitemid 27358009)
39. R.H. Getzenberg, B.W. Light, P.E. Lapco, B.R. Konety, A.K. Nangia, J.S. Acierno, R. Dhir, Z. Shurin, R.S. Day, D.L. Trump, and C.S. Johnson Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system Urology 50 6 1997 999 1006 (Pubitemid 28021128)
40. K.W. Colston, S.K. Chander, A.G. Mackay, and R.C. Coombes Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro Biochem. Pharmacol. 44 4 1992 693 702
41. 3 is a preventive factor in the metastasis of lung cancer Carcinogenesis 26 2 2005 429 440 (Pubitemid 40246565)
42. R. Bouillon, W.H. Okamura, and A.W. Norman Structure-function relationships in the vitamin D endocrine system Endocr. Rev. 16 2 1995 200 257
43. 3 activate three MAPK pathways and upregulate pRb expression in differentiating HL60 cells Cell Cycle 1 6 2002 410 415
44. 3 metabolism enhances VDR signalling in androgen-independent prostate cancer cells J. Steroid Biochem. Mol. Biol. 98 4-5 2006 228 235 (Pubitemid 43344252)